Pillsbury Winthrop Shaw Pittman LLP advised Quino Energy on the deal. Quino Energy, a California-based clean-tech startup company, announced a $3.3 million seed financing round led by...
Quino Energy’s $3.3 Million Seed Financing Round
KnowBe4’s $4.6 Billion Going-Private Transaction
Wilson Sonsini Goodrich & Rosati advised KnowBe4 and Potter Anderson & Corroon advised the Special Committee. Latham & Watkins represented Elephant Partners. Gibson, Dunn & Crutcher...
Pathfinder Acquisition Corporation’s Business Combination with Movella
Kirkland & Ellis advised Pathfinder Acquisition Corporation on the deal, Pillsbury Winthrop Shaw Pittman advised Movella, Latham & Watkins advised Francisco Partners. Pathfinder Acquisition Corporation (NASDAQ:...
Centricus’ Acquisition of Majority Stake in SK Global Entertainment
Latham & Watkins represented Centricus in the transaction. Centricus, the London-based global investment firm, has acquired a majority stake in SK Global Entertainment, a leading independent...
Alpine Immune Sciences’ $100 Million Shares Offering
Wilson Sonsini Goodrich & Rosati represented Alpine, while Latham & Watkins represented to underwriters in the offering. Alpine Immune Sciences, Inc. (Nasdaq: ALPN) has announced the pricing...
IDEAYA Biosciences’ $80 Million Common Stock Offering
Latham & Watkins represented IDEAYA, while Davis Polk advised the representatives of the several underwriters in the offering. IDEAYA Biosciences, Inc. (Nasdaq: IDYA) announced the pricing of an...
Arista Networks’ Acquisition of Pluribus Networks
Pillsbury Winthrop Shaw Pittman LLP advised Pluribus Networks on the deal. Pluribus Networks, Inc., a unified cloud networking company delivering solutions based on the principles of...
Bloom Energy’s $338 Million Shares Offering
Latham & Watkins represented Bloom Energy in the transaction, while Davis Polk advised the underwriters. Bloom Energy Corporation (NYSE: BE), the developer of a solid-oxide platform for...
Mirum Pharmaceuticals’ $80 Million Common Stock Offering
Cooley represented Mirum Pharmaceuticals, while Latham & Watkins represented the underwriters in the offering. Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the identification, acquisition,...
Arcutis Biotherapeutics’ $150 Million Shares Offering
Latham & Watkins advised Arcutis Biotherapeutics, Inc. in the offering, while Cooley represented the underwriters. Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) has announced the pricing of its underwritten...
Quantum Corporation’s $67.5 Million Rights Offering
Pillsbury advised Quantum Corporation on the deal. Quantum Corporation announced the closing of its recent Rights Offering. Through broad participation from outside investors and with all eligible...
Revolution Medicines’ $230 Million Shares Offering
Latham & Watkins represented Revolution Medicines, while Davis Polk advised the underwriters in the offering. Revolution Medicines, Inc. (Nasdaq: RVMD), has announced the pricing of its underwritten...